Vous êtes ici

Glucose-lowering drugs or strategies and cardiovascular outcomes in patients with or at risk for type 2 diabetes: a meta-analysis of randomised controlled trials

The Lancet Diabetes & Endocrinology

Note 1 sur 3
Udell JA, Cavender MA, Bhatt DL, et al. Lancet Diabetes Endocrinol 2015;3:356-66